Immuneering Corporation (IMRX)
NASDAQ: IMRX · Real-Time Price · USD
1.180
-0.010 (-0.84%)
Sep 6, 2024, 4:00 PM EDT - Market closed
Immuneering Market Cap
Immuneering has a market cap or net worth of $34.99 million as of September 6, 2024. Its market cap has decreased by -88.04% in one year.
Market Cap
34.99M
Enterprise Value
-20.43M
1-Year Change
-88.04%
Ranking
Category
Stock Price
$1.18
Market Cap Chart
Since the IPO on July 30, 2021, Immuneering's market cap has decreased from $365.84M to $34.99M, a decrease of -90.44%. That is a compound annual growth rate of -53.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 6, 2024 | 35.00M | -83.73% |
| Dec 29, 2023 | 215.10M | 67.92% |
| Dec 30, 2022 | 128.10M | -69.46% |
| Dec 31, 2021 | 419.50M | 14.67% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lantern Pharma | 38.86M |
| Bright Green | 37.66M |
| Inotiv | 37.45M |
| Dyadic International | 37.44M |
| OKYO Pharma | 37.22M |
| Moolec Science | 36.80M |
| Ocean Biomedical | 36.38M |
| vTv Therapeutics | 36.37M |